While previous academic studies have used antibody panels to detect the spectrum of tau PTMs in mouse models of AD [20, 21], our study significantly expands the spectrum of available methods by covering more PTMs and providing thorough validation of all antibodies used. Here, MAPT is linked to Alzheimer disease.